0 CHECKOUT

PRODUCT FILTERS

REGION

75
51
49
42
30

COUNTRY

23
19
17
13

CATEGORIES

  • 131
  • 28
  • 20
  • 19
  • 11
  • 8
  • 7
  • 6
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

42
161
177
257

PUBLISHED

2
9
69
257

PRODUCT TYPE

234
17
3
2
1

Search for: "U.S. Anticoagulant Market"

The 2016-2021 Outlook for Anticoagulants in the United States

WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is...

Published:  September 2015
Price: 

The 2016-2021 Outlook for Anticoagulant Pharmaceutical Preparations in the United States

WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is...

Published:  September 2015
Price: 

The 2013-2018 Outlook for Anticoagulant Pharmaceutical Preparations in the United States

WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the...

Published:  January 2013
Price: 

The 2011-2016 Outlook for Anticoagulants in the United States

WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the...

Published:  January 2011
Price:  From

The 2011-2016 Outlook for Anticoagulant Pharmaceutical Preparations in the United States

WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the...

Published:  February 2011
Price:  From

Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019

Rodenticides Market by Type (Anticoagulants, Non-Anticoagulants, and Others), by End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers, and Others) & by Geography - Global...

Published:  July 2014
Price:  From

Anticoagulants - Global Strategic Business Report

This report analyzes the worldwide markets for Anticoagulants in Millions of US$ by the following Product Segments: Oral Anticoagulants, and Injectable Anticoagulants (Unfractionated Heparin, and Low...

Published:  October 2012
Price:  From

Will Next Generation Oral Anticoagulants Replace Warfarin as Mainstay Therapy?

Will Next Generation Oral Anticoagulants Replace Warfarin as Mainstay Therapy? Pradaxa: With a first mover advantage, Will it be the Leader in SPAF? Xarelto: Is it the future mainstay anticoagulant...

Published:  August 2011
Price:  From

New Oral Anticoagulants Markets

Anticoagulants decrease the ability of the blood to create harmful blood clots that can ultimately leading to a heart attack or stroke Although sometimes referred to as blood thinners, they do not actually...

Published:  March 2013
Price:  From

Edoxaban - Potential Game Changer in Oral Anticoagulant Market

Edoxaban - Potential Game changer in oral anticoagulant market Stroke Prevention in Atrial Fibrillation represents the largest opportunity for the new generation oral anticoagulants, besides a very...

Published:  September 2012
Price:  From

Stroke: Competing Treatments and Market Entry Considerations

This report presents the findings of a global survey on current treatments and prescribing practices for Ischaemic Stroke, Haemorrhagic Stroke and Transient Ischaemic Attack (TIA) These findings were...

Published:  June 2010
Price:  From

Factor Xa Inhibitors: Competition for market share in this new class of anticoagulants

Factor Xa inhibitors are the most likely new oral anticoagulants to reach the market The class is led by Bayer/J&J's rivaroxaban (Xarelto), approved in Europe but not yet in the US Seven other agents...

Published:  January 2010
Price:  From

Physician Views: How do European Cardiologists Perceive Oral Anticoagulants Versus Warfarin? – Is Eliquis, Pradaxa or Xarelto their Favoured Option?

Sales forecasts for Bristol-Myers Squibb and Pfizer's anticoagulant product Eliquis have declined notably in recent months. According to Bloomberg, current consensus estimates suggest 2018 global revenues...

Published:  September 2013
Price:  From

New Anticoagulant Therapies: A Market Briefing

There is a pressing need for new anticoagulant therapeutics in human medicine. To meet this need, developers are reformulating traditional cornerstone therapeutics such as heparin and looking to new...

Published:  October 2004
Price:  From

Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the Market

Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the Market Summary Our report, “Anticoagulants in Stroke Prevention...

Published:  November 2010
Price:  From

Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes

Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes Summary Our report, “Failure...

Published:  November 2010
Price:  From

Generic Drug Opportunity Assessment - Apixaban (Eliquis)

The branded drug Eliquis (apixaban) represents an attractive opportunity for generic drug companies that utilize the provisions under Section 505(j)(2)(A)(vii)(IV) as part of their ANDA-filing strategy...

Published:  January 2014
Price:  From

US Market for Hemostasis Devices - 2016 (Forecasted to 2022)

This segment includes only the analyzers and reagents used in core labs of hospitals and in independent commercial labs, without taking into consideration the point-of-care (POC) equipment. The U.S....

Published:  October 2015
Price:  From

Injectable Drug Delivery Global Market Analysis - Forecast (2014-2020)

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique...

Published:  July 2015
Price:  From

Hypertrophic Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023

This report on the hypertrophic cardiomyopathy therapeutics market studies the current and future prospects of the global market. Hypertrophic cardiomyopathy occurs if heart muscle cells enlarge and...

Published:  November 2015
Price:  From
Loading Indicator

Our Clients

  • Hewlett-Packard Company
  • Microsoft Corporation
  • Philips N.V.
  • SONY Corporation
  • Cypress Semiconductor Corporation
  • Panasonic Corporation